CG
ONCS

Cutler Group’s OncoSec Medical Incorporated ONCS Stock Holding History

Cutler Group’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-32
Closed – – 6479
2021
Q4 		$0 Sell
32
-23
-42% -$777 ﹤0.01% 6565
2021
Q3 		$2K Buy
+55
New +$2.79K ﹤0.01% 5199

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Cutler Group's ONCS Position: Q1 2022 in Review

Cutler Group sold out of OncoSec Medical Incorporated (ONCS) in Q1 2022, closing a stake of 32 shares.

Cutler Group first reported a position in ONCS in Q3 2021 and held it in 2 quarters. The position peaked at $2K in Q3 2021. 28 funds tracked by Wall St. Rank hold ONCS as of Q1 2022.

  • Cutler Group reported no remaining OncoSec Medical Incorporated position as of Q1 2022 after selling out during the quarter.
  • Cutler Group sold 32 OncoSec Medical Incorporated shares in Q1 2022.
  • Cutler Group first reported a position in OncoSec Medical Incorporated in Q3 2021 and held it in 2 quarters.
  • Cutler Group's OncoSec Medical Incorporated position peaked at $2K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.